Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T15:35:22.221Z.
Calculation as of: 2026-10-06T15:35:22.221Z.
Quote observation: 2026-10-06T15:34:35.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e8c4723d74b6f0443862f85907ca9030ea6941843cb736177163438a313e1ca1
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Alpha Cognition Inc
Market Cap
$139.63M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$139.73M
Operating Cash Flow Yield
90.12%
TTM Avg
20.54%
3Y Avg
20.54%
5Y Avg
20.54%
Market Cap
$141.83M
Operating Cash Flow Yield
0.90%
TTM Avg
3.24%
3Y Avg
4.92%
5Y Avg
5.15%
Market Cap
$136.88M
Operating Cash Flow Yield
1.02%
TTM Avg
0.36%
3Y Avg
0.36%
5Y Avg
0.36%
Market Cap
$136.52M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$135.17M
Operating Cash Flow Yield
N/A
TTM Avg
6.01%
3Y Avg
5.49%
5Y Avg
5.49%
Market Cap
$146.12M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alpha Cognition Inc (ACOG) | $139.63M | N/A | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIOP)vs › | $139.73M | 90.12% | 20.54% | 20.54% | 20.54% |
| AirSculpt Technologies, Inc. (AIRS)vs › | $141.83M | 0.90% | 3.24% | 4.92% | 5.15% |
| KORU Medical Systems, Inc. (KRMD)vs › | $136.88M | 1.02% | 0.36% | 0.36% | 0.36% |
| Pyxis Oncology, Inc. (PYXS)vs › | $136.52M | N/A | N/A | N/A | N/A |
| Nyxoah S.A. (NYXH)vs › | $143.60M | N/A | N/A | N/A | N/A |
| Freenome, Inc. (FRNM)vs › | $135.70M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMD)vs › | $135.17M | N/A | 6.01% | 5.49% | 5.49% |
| Immuneering Corporation (IMRX)vs › | $146.12M | N/A | N/A | N/A | N/A |
| Korsana Biosciences, Inc. (KRSA)vs › | $146.58M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
